Validity of the Somatic Complaints Scales of the MMPI‑2‑RF in an Outpatient Chronic Pain Clinic

View/ Open
Date
2021-02-22Author
Mickens, Lauren
Nghiem, Duyen
Wygant, Dustin
Umlauf, Robert
Marek, Ryan
Metadata
Show full item recordAbstract
Chronic pain has become a significant medical issue. The Minnesota Multiphasic Personality Inventory-2-Restructured
Form (MMPI-2-RF) is a broadband psychological test that has been validated for use across various medical settings and
can aid in the assessment and treatment planning of chronic pain. In the current investigation, it was hypothesized that the
somatic complaints scales of the MMPI-2-RF would demonstrate good convergent validity from a structured psychodiagnostic
interview and other measures of pain and somatization, and lack gender bias. Patients (n = 200) who produced valid
MMPI-2-RFs in an outpatient chronic pain clinic were included in the study. Patients were also administered the Modified
Somatic Perception Questionnaire (MSPQ), Pain Disability Index (PDI), and the Structured Clinical Interview for DSM-IVTR
(SCID). Zero-order and partial correlations (controlling for gender) were calculated between MMPI-2-RF scale scores
and other criteria. Stepdown hierarchical regression analyses were used to detect bias. By and large, higher scale scores on
the somatic/cognitive scales of the MMPI-2-RF were modestly or substantially correlated with MSPQ scores, PDI scores,
and SCID Somatization symptom count, even after controlling for gender. Regression analyses suggested that the MMPI-
2-RF scale scores were not biased as a function of gender. These findings support the validity of specific MMPI-2-RF scales
to help identify somatization and psychosocial functioning among patients with chronic pain. Identification of somatization
early within the course of treatment of chronic pain may help focus treatment targets, including referrals for psychological
interventions such as cognitive behavior therapy for chronic pain.